Product guide · Restricted substance
Hardcore MYO TKO
Research compound from Savage Line Labs. This guide sets out what the manufacturer states about the composition of Hardcore MYO TKO, what independent research says about its main ingredients, and the safety and regulatory points that apply. It contains substances that are not authorised as food or medicine in the EU. This guide is educational: it does not recommend use and gives no directions for use.
Back to the product- Named ingredients
- 11
- Amounts stated
- 10 of 11
- Status
- Restricted substance
- Evidence summaries
- 11
Overview
Manufacturer informationIngredients & composition
Manufacturer information| Ingredient | Amount |
|---|---|
| Vitamin C | 250 mg |
| Beta-alanine | 2500 mg |
| Agmatine | 500 mg |
| Higenamine | 50 mg |
| Caffeine | 500 mg |
| DMAA | 75 mg |
| Citrulline | 2000 mg |
| Niacin | 25 mg |
| Tyrosine | 1000 mg |
| Ostarine (MK-2866) | 5 mg |
| Yohimbine | Not stated |
The manufacturer does not state the amount of 1 of the 11 ingredients. Without amounts, the research summarised in this guide cannot be related to this product's dose.
Serving size stated by the manufacturer: 7.7 g.
Scientific background
Independent researchVitamin C (ascorbic acid)
Vitamin C is a water-soluble vitamin needed for collagen formation, immune function and iron absorption. EFSA set population reference intakes of 110 mg a day for men and 95 mg a day for women2.
Beta-alanine
Beta-alanine is an amino acid that combines with histidine in muscle to form carnosine, which helps buffer acid during intense exercise3.
Agmatine sulfate
Agmatine is formed in the body from the amino acid arginine and acts as a signalling molecule in the nervous system. It is sold as agmatine sulfate in sports and nootropic products.
Higenamine
Higenamine is a plant alkaloid that stimulates β2-adrenergic receptors, the same receptor family targeted by asthma bronchodilators. It is found in plants such as Nandina domestica4.
Caffeine
Caffeine is a stimulant that blocks adenosine receptors in the brain, reducing perceived effort and fatigue. It is found in coffee, tea and energy drinks and is a common ingredient in pre-workout products5.
Dicaffeine malate (sold as Infinergy®) is caffeine bonded to malic acid. Its caffeine adds to the total caffeine in a product, but labels do not always state the caffeine equivalent.
DMAA (1,3-dimethylamylamine)
DMAA (1,3-dimethylamylamine, methylhexanamine) is a synthetic stimulant that constricts blood vessels and raises blood pressure. It has been sold in pre-workout and weight-loss supplements and as a recreational stimulant6.
L-citrulline and citrulline malate
L-citrulline is an amino acid that the body converts to arginine, a precursor of nitric oxide, which widens blood vessels. Citrulline malate combines citrulline with malic acid7.
Niacin (vitamin B3: nicotinic acid, niacinamide)
Niacin (vitamin B3) is used to make the coenzymes NAD and NADP, which are central to energy metabolism. It exists as nicotinic acid and nicotinamide (niacinamide)8.
L-tyrosine
L-tyrosine is an amino acid that the body uses to make the neurotransmitters dopamine and noradrenaline. It is found in protein-rich foods; N-acetyl-L-tyrosine is a related form9.
Ostarine (MK-2866, enobosarm)
Ostarine (also called MK-2866, GTx-024 or enobosarm) is a selective androgen receptor modulator developed as an investigational drug for muscle wasting10. OTR-AC is marketed as an acetylated (ester) form of ostarine; no human research on it has been published.
Yohimbine (yohimbe bark, rauwolscine)
Yohimbine is an alkaloid from the bark of the African tree Pausinystalia yohimbe. It blocks α2-adrenergic receptors, which increases noradrenaline release. Rauwolscine (alpha-yohimbine) is a closely related alkaloid.
Research evidence
Independent researchVitamin C (ascorbic acid)
Authorised EU claims include that vitamin C contributes to normal collagen formation, normal immune function, the reduction of tiredness and fatigue, and increased iron absorption11.
Beta-alanine
The International Society of Sports Nutrition concludes that 4–6 g a day for at least 2–4 weeks raises muscle carnosine and improves performance in exercise lasting about 1–4 minutes3.
A meta-analysis found a significant overall ergogenic effect, with the size of the benefit depending on the type and duration of exercise12.
Agmatine sulfate
Controlled human research on agmatine for exercise performance is very limited. Published human data are mostly small studies and a long-term case report13.
Higenamine
There are no controlled human trials showing that higenamine improves exercise performance or weight loss. Analyses of US supplements found up to about 62 mg per serving, with labels that often did not state the amount4.
Caffeine
The International Society of Sports Nutrition concludes that caffeine consistently improves exercise performance when consumed in doses of about 3–6 mg per kg of body mass, with benefits for muscular endurance, movement velocity, strength, sprinting, jumping and aerobic exercise5.
DMAA (1,3-dimethylamylamine)
No controlled trials show that DMAA improves athletic performance or weight loss. A pharmacokinetic study of a single 25 mg dose did not find meaningful changes in resting heart rate, blood pressure or body temperature14.
L-citrulline and citrulline malate
A review of human studies found that citrulline supplementation raises plasma arginine, and that several studies report improved exercise performance or recovery, but the results are inconsistent7.
Niacin (vitamin B3: nicotinic acid, niacinamide)
Authorised EU claims include that niacin contributes to normal energy-yielding metabolism, the reduction of tiredness and fatigue, and the maintenance of normal skin11.
L-tyrosine
A review found that tyrosine may support cognitive performance in short-term stressful or cognitively demanding situations, when these neurotransmitters are temporarily depleted, but found no consistent effect on physical exercise performance9.
Ostarine (MK-2866, enobosarm)
A phase 2 trial in healthy older men and postmenopausal women found a dose-dependent increase in lean body mass and physical function over 12 weeks10. A phase 2 trial in people with cancer reported improved lean body mass15. These are clinical-development studies in specific patient groups, not studies of sports or bodybuilding use.
Yohimbine (yohimbe bark, rauwolscine)
A small trial in professional soccer players found reduced body fat with yohimbine but no change in body mass, muscle mass or performance16. Larger, independent trials are lacking.
Evidence limitations
Independent researchThis product does not state all ingredient amounts, so the doses used in research cannot be compared with what one serving provides.
The studies summarised in this guide examined single ingredients. No published study has tested this product or this combination of ingredients.
Vitamin C (ascorbic acid)
Intakes above needs are largely excreted; extra benefit from high doses is not established.
Beta-alanine
Effects on strength and on endurance exercise beyond about 25 minutes are not established3. A single serving taken before training does not reproduce the daily supplementation used in research.
Agmatine sulfate
There are no large randomised trials showing a performance benefit from agmatine in healthy people. Claims of better "pump" or focus are not established.
Higenamine
Published research concerns supplement analysis rather than effects in humans4.
Caffeine
Responses vary widely between people, partly because of genetics and habitual caffeine use. Many studies use pure caffeine, so results do not automatically apply to multi-ingredient products5.
DMAA (1,3-dimethylamylamine)
The single-dose study does not reflect repeated use, higher doses or combination with other stimulants and exercise14. Analyses of sports and weight-loss supplements have repeatedly found stimulants that were not declared, or quantities different from the label1718.
L-citrulline and citrulline malate
Studies differ in dose, form (citrulline or citrulline malate, often with an unverified ratio) and exercise test, and many are small. The mechanism behind any performance effect is not established7.
Niacin (vitamin B3: nicotinic acid, niacinamide)
Benefits of intakes well above needs are not established in people who are not deficient.
L-tyrosine
Most studies are small and use single doses in laboratory settings9.
Ostarine (MK-2866, enobosarm)
Phase 2 results do not establish efficacy or long-term safety, and the compound has not been approved as a medicine. Analyses of products sold online as SARMs found that many did not contain the substance or amount stated on the label, and some contained other unapproved drugs19.
Yohimbine (yohimbe bark, rauwolscine)
Evidence for fat loss or performance is limited to small studies. Supplement labels are often inaccurate: of 49 US yohimbine supplements tested, only 2 gave accurate information on both the quantity and the known adverse effects20.
Safety & potential risks
For this product
The manufacturer states 500 mg of caffeine (as stated). That is more than the 200 mg single dose that EFSA considers safe for healthy adults, and more than the 400 mg it considers safe for a whole day1. Avoid other caffeine sources and do not exceed the label serving.
Vitamin C (ascorbic acid)
No tolerable upper intake level has been set; high doses can cause digestive upset. People with a history of kidney stones or iron overload should ask a doctor before taking high doses.
Beta-alanine
The only commonly reported side effect is paraesthesia, a harmless tingling of the skin that is more likely with larger single doses3.
Agmatine sulfate
A case report described 5 years of high daily agmatine intake without detected adverse effects13. One case report cannot establish safety for the wider population.
Higenamine
As a β2-agonist, higenamine may raise heart rate and cause palpitations, and its safety at supplement doses has not been established4.
Caffeine
EFSA concluded that single doses of up to 200 mg, and daily intakes of up to 400 mg from all sources, do not raise safety concerns for healthy adults. For pregnant and breastfeeding women, daily intakes up to 200 mg do not raise concerns for the foetus or infant1.
Higher intakes can cause anxiety, sleep disturbance, raised heart rate and blood pressure, and digestive upset. Combining several caffeine sources (coffee, energy drinks, pre-workouts) raises total intake15.
DMAA (1,3-dimethylamylamine)
DMAA is a potent pressor agent. Cases of cerebral haemorrhage have been reported in adults after using DMAA6.
L-citrulline and citrulline malate
Citrulline is generally well tolerated in the doses studied. Digestive discomfort has been reported, and people taking blood-pressure or erectile-dysfunction medication should ask a doctor, because citrulline raises arginine and nitric oxide production7.
Niacin (vitamin B3: nicotinic acid, niacinamide)
The EU Scientific Committee on Food set separate upper levels: 10 mg a day for nicotinic acid, which causes flushing, and 900 mg a day for nicotinamide21. "Flush-free" products use nicotinamide or inositol hexanicotinate.
L-tyrosine
People taking MAO inhibitors or thyroid medication should not use tyrosine supplements without medical advice.
Ostarine (MK-2866, enobosarm)
A systematic review of SARM use by athletes reports liver toxicity, heart toxicity, tendon damage, suppression of natural testosterone and other androgenic effects22. A national case series linked SARMs and other bodybuilding products to drug-induced liver injury23.
Yohimbine (yohimbe bark, rauwolscine)
A review of poison-centre cases found that adverse events with yohimbine products had more serious outcomes than average exposures, including rapid heart rate, anxiety, high blood pressure and agitation24. People with heart conditions, high blood pressure, anxiety disorders or taking antidepressants should not use yohimbine.
Regulatory status
Contains a selective androgen receptor modulator (SARM). SARMs are investigational substances that are not authorised as medicinal products or as food (including food supplements) in the EU and are on the World Anti-Doping Agency (WADA) Prohibited List. Contains 1,3-dimethylamylamine (DMAA), a synthetic stimulant that is not authorised as a novel food in the EU and is on the WADA Prohibited List. Contains higenamine and/or octopamine, which are on the WADA Prohibited List. Contains yohimbine. Isolated yohimbine is classified as a medicinal substance in several EU member states; its legal status depends on the country of sale. No dosing information for human use is provided.
Vitamin C (ascorbic acid)
It is a permitted nutrient in EU food supplements25; authorised claims may only be used in their approved wording and when the product is at least a source of the nutrient11.
Beta-alanine
Beta-alanine is used in EU food supplements under national rules. No health claim is authorised11.
Agmatine sulfate
Agmatine sulfate is used in some EU food supplements under national rules. No health claim is authorised11. Whether a product needs novel food authorisation depends on its history of use26.
Higenamine
Higenamine is not an authorised food supplement ingredient in the EU26 and is prohibited at all times by the World Anti-Doping Agency as a β2-agonist1827.
Caffeine
Caffeine is permitted in EU foods and food supplements, subject to labelling rules. It is not on the World Anti-Doping Agency Prohibited List27.
DMAA (1,3-dimethylamylamine)
DMAA is not authorised as food or as a food supplement ingredient in the EU26 and is prohibited in competition by the World Anti-Doping Agency1727.
L-citrulline and citrulline malate
L-citrulline is used in EU food supplements under national rules. No health claim for citrulline is authorised in the EU11.
Niacin (vitamin B3: nicotinic acid, niacinamide)
It is a permitted nutrient in EU food supplements25; authorised claims may only be used in their approved wording and when the product is at least a source of the nutrient11.
L-tyrosine
Amino acids such as L-tyrosine are used in EU food supplements under national rules. No health claim is authorised11.
Scientific references
- EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on the safety of caffeine. EFSA Journal. 2015;13(5):4102. DOI 10.2903/j.efsa.2015.4102
- EFSA NDA Panel. Scientific Opinion on Dietary Reference Values for vitamin C. EFSA Journal. 2013;11:3418. DOI 10.2903/j.efsa.2013.3418
- Trexler ET, Smith-Ryan AE, Stout JR, et al. International society of sports nutrition position stand: beta-alanine. J Int Soc Sports Nutr. 2015;12:30. PubMed 26175657
- Cohen PA, Travis JC, Keizers PHJ, et al. The stimulant higenamine in weight loss and sports supplements. Clin Toxicol (Phila). 2019;57:125-130. PubMed 30188222
- Guest NS, VanDusseldorp TA, Nelson MT, et al. International Society of Sports Nutrition position stand: caffeine and exercise performance. J Int Soc Sports Nutr. 2021;18:1. PubMed 33388079
- Gee P, Tallon C, Long N, et al. Use of recreational drug 1,3-dimethylamylamine (DMAA) associated with cerebral hemorrhage. Ann Emerg Med. 2012;60:431-434. PubMed 22575212
- Gonzalez AM, Trexler ET. Effects of citrulline supplementation on exercise performance in humans: a review of the current literature. J Strength Cond Res. 2020;34:1480-1495. PubMed 31977835
- EFSA NDA Panel. Scientific Opinion on Dietary Reference Values for niacin. EFSA Journal. 2014;12:3759. DOI 10.2903/j.efsa.2014.3759
- Jongkees BJ, Hommel B, Kühn S, et al. Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands: a review. J Psychiatr Res. 2015;70:50-57. PubMed 26424423
- Dalton JT, Barnette KG, Bohl CE, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle. 2011;2:153-161. PubMed 22031847
- Commission Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods. Official Journal of the European Union. Source
- Saunders B, Elliott-Sale K, Artioli GG, et al. β-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis. Br J Sports Med. 2017;51:658-669. PubMed 27797728
- Gilad GM, Gilad VH. Long-term (5 years), high daily dosage of dietary agmatine: evidence of safety: a case report. J Med Food. 2014;17:1256-1259. PubMed 25247837
- Schilling BK, Hammond KG, Bloomer RJ, et al. Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men. BMC Pharmacol Toxicol. 2013;14:52. PubMed 24090077
- Dobs AS, Boccia RV, Croot CC, et al. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol. 2013;14:335-345. PubMed 23499390
- Ostojic SM. Yohimbine: the effects on body composition and exercise performance in soccer players. Res Sports Med. 2006;14:289-299. PubMed 17214405
- Cohen PA, Travis JC, Keizers PHJ, et al. Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA). Clin Toxicol (Phila). 2018;56:421-426. PubMed 29115866
- Cohen PA, Travis JC, Vanhee C, et al. Nine prohibited stimulants found in sports and weight loss supplements. Clin Toxicol (Phila). 2021;59:975-981. PubMed 33755516
- Van Wagoner RM, Eichner A, Bhasin S, et al. Chemical composition and labeling of substances marketed as selective androgen receptor modulators and sold via the internet. JAMA. 2017;318:2004-2010. PubMed 29183075
- Cohen PA, Wang YH, Maller G, et al. Pharmaceutical quantities of yohimbine found in dietary supplements in the USA. Drug Test Anal. 2016;8:357-369. PubMed 26391406
- Scientific Committee on Food / EFSA. Tolerable Upper Intake Levels for Vitamins and Minerals. European Food Safety Authority; 2006. Source
- Vasireddi N, Hahamyan HA, Gould HP, et al. Athlete selective androgen receptor modulators abuse: a systematic review. Am J Sports Med. 2025;53:999-1009. PubMed 39755947
- Nash E, Nicoll A, Batt N, et al. Drug-induced liver injury from selective androgen receptor modulators, anabolic-androgenic steroids and bodybuilding supplements in Australia. Aliment Pharmacol Ther. 2024;59:953-961. PubMed 38372012
- Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases. Ann Pharmacother. 2010;44:1022-1029. PubMed 20442348
- Directive 2002/46/EC on the approximation of the laws of the Member States relating to food supplements. Official Journal of the European Union. Source
- Regulation (EU) 2015/2283 on novel foods. Official Journal of the European Union. Source
- World Anti-Doping Agency. The Prohibited List (current edition). Source
- Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union. Source
- Thevis M, Schänzer W. Detection of SARMs in doping control analysis. Mol Cell Endocrinol. 2018;464:34-45. PubMed 28137616
- Regulation (EC) No 1925/2006 on the addition of vitamins and minerals and of certain other substances to foods. Official Journal of the European Union. Source
Sources checked against PubMed, Crossref or the official publisher on 2026-11-04. Manufacturer information is taken from the product's own data and has not been independently tested.

The product
Hardcore MYO TKO
€49,00 · Sold out